Clinical endocannabinoid deficiency (CECD): Can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions
Effects of anandamide in migraine: data from an animal model
Cannabinoids and hallucinogens for headache
The endocannabinoid system and migraine
Variations in the cannabinoid receptor 1 gene predispose to migraine
